Trending...
- Custom Home Builder Connecticut Valley Homes Wins 2025 Home of the Year from the Modular Home Builders Association
- Revenue Optics Appoints Ljupco Icevski as Executive Advisor in Strategic Move to Accelerate Commercial Development
- Creators' Rights Movement Advances Copyright Rights and Generational Ownership
NEW YORK, Nov. 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Viking Therapeutics, Inc. ("Viking" or the "Company") (NASDAQ: VKTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Viking and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On November 3, 2024, Viking released positive trial data for VK2735, the Company's anti-obesity drug, as part of a presentation at the Obesity Week medical meeting, causing Viking's stock price to climb 9% during intraday trading on November 4, 2024. However, analysts were quick to note that Viking may face production problems for VK2735, especially for 100mg or higher doses. Analysts at Deutsche Bank stated in a note that scaling up production for the drug "will be costly with capital requirements and expertise beyond what [Eli] Lilly (LLY) and Novo [Nordisk] (NVO) currently have[.]"
More on Nyenta.com
Following these reports, Viking's stock price fell $9.74 per share, or 13.36%, to close at $63.14 per share on November 4, 2024.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
SOURCE Pomerantz LLP
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
GET STARTED
The investigation concerns whether Viking and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On November 3, 2024, Viking released positive trial data for VK2735, the Company's anti-obesity drug, as part of a presentation at the Obesity Week medical meeting, causing Viking's stock price to climb 9% during intraday trading on November 4, 2024. However, analysts were quick to note that Viking may face production problems for VK2735, especially for 100mg or higher doses. Analysts at Deutsche Bank stated in a note that scaling up production for the drug "will be costly with capital requirements and expertise beyond what [Eli] Lilly (LLY) and Novo [Nordisk] (NVO) currently have[.]"
More on Nyenta.com
- Members Heritage Credit Union Taps Scienaptic AI to Power Frictionless, Inclusive Credit Decisions and Transform Lending
- Rigani Press Announces Ebook Version Now Available for RUSHING HEADLONG by S. Yin Ho
- Mom of Two Turns Parenting Frustration Into Viral Baby Product
- New Analysis Reveals Most Patients Discontinue Weight Loss Drugs Within First Year
- The new geography of global wealth: why investors are shifting capital to more stable financial hubs
Following these reports, Viking's stock price fell $9.74 per share, or 13.36%, to close at $63.14 per share on November 4, 2024.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
SOURCE Pomerantz LLP
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
GET STARTED
Filed Under: Business
0 Comments
Latest on Nyenta.com
- Yonkers: NOMINATIONS FOR YONKERS 2026 TEACHER OF THE YEAR AWARDS NOW OPEN
- Premium Bail Bonds Proudly Sponsors BOFAB BBQ Team at the 2026 Lakeland Pigfest
- UK Financial Ltd Receives Recognition In Platinum Crypto Academy's "Cryptonaire Weekly"
- Professional Women Photographers Open Call: Small Works — A Fundraiser Exhibition
- P-Wave Press Announces Pushing the Wave 2024 by L.A. Davenport
- Jewellery Trends 2026: The New Rules of Shine (and How to Wear Them)
- Preston Dermatology & Skin Surgery Center Wins Gold and Bronze in Prestigious Annual DIAMOND Awards
- Daniel Cohen Achieves 5 Year Super Lawyers Rising Stars Recognition and Lawyers of Distinction Award
- David Boland, Inc. Awarded $54.3M Construction Contract by U.S. Army Corps of Engineers, Savannah District
- "Phinge Unveilâ„¢" Coming to Las Vegas to Showcase Netverse Patented Verified App-less Platform, AI & Modular Hardware Including Developer Conferences
- Elizabeth McLaughlin, Founder and CEO of Red Wagon Group, named 2026 Presidential Leadership Scholar
- U.S. Congressional Candidate Peter Coe Verbica on America's Asymmetric Crisis
- RKP Media Partners With Santani To Elevate Luxury Wellness Brand
- Jones Sign Rebrands as Jones to Reflect Growth, Innovation, and Expanded Capabilities
- Invenio IT Announces Launch of Datto SIRIS 6: The Next Generation of Business Continuity and Disaster Recovery
- Latoya Shea Releases Becoming: The Story of Grace After the Fall
- $1 Million Share Repurchase Signals Confidence as Off The Hook YS Scales a Tech-Driven Platform in the $57 Billion U.S. Marine Market
- Yonkers: MAYOR SPANO INVITES YONKERS COUPLES CELEBRATING 50 YEARS OR MORE OF MARRIAGE IN 2026
- GOOD NEWS! How did God bless 22 Prayer Warriors who prayed for their neighbors one by one, name by n
- Trends Journal's Top Trends of 2026